
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
SSE:600513.SS
10 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,160.457 | 2,174.1 | 1,955.157 | 1,645.816 | 1,386.039 | 1,290.333 | 1,019.239 | 689.099 | 604.861 | 642.433 | 668.688 | 623.303 | 325.359 | 324.215 | 289.442 | 259.894 | 225.373 | 194.783 | 166.24 | 172.994 | 181.194 | 112.338 | 78.508 | 69.245 | 64.695 |
Cost of Revenue
| 1,093.744 | 1,130.102 | 912.117 | 746.694 | 639.832 | 513.695 | 320.074 | 214.184 | 251.084 | 276.581 | 320.814 | 334.401 | 148.135 | 163.004 | 148.546 | 133.26 | 117.801 | 103.201 | 86.722 | 98.296 | 114.104 | 65.455 | 31.039 | 28.777 | 33.092 |
Gross Profit
| 1,066.714 | 1,043.998 | 1,043.04 | 899.123 | 746.207 | 776.638 | 699.165 | 474.915 | 353.777 | 365.852 | 347.874 | 288.902 | 177.224 | 161.211 | 140.896 | 126.634 | 107.572 | 91.582 | 79.517 | 74.697 | 67.09 | 46.883 | 47.469 | 40.467 | 31.603 |
Gross Profit Ratio
| 0.494 | 0.48 | 0.533 | 0.546 | 0.538 | 0.602 | 0.686 | 0.689 | 0.585 | 0.569 | 0.52 | 0.464 | 0.545 | 0.497 | 0.487 | 0.487 | 0.477 | 0.47 | 0.478 | 0.432 | 0.37 | 0.417 | 0.605 | 0.584 | 0.488 |
Reseach & Development Expenses
| 154.589 | 133.148 | 92.439 | 66.474 | 44.018 | 46.968 | 38.058 | 20.484 | 16.826 | 16.023 | 11.25 | 12.3 | 11.3 | 4.892 | 6.496 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 28.798 | 18.753 | 24.447 | 19.313 | 27.006 | 22.837 | 19.277 | 14.659 | 9.093 | 8.513 | 11.439 | 10.598 | 2.474 | 3.835 | 4.881 | 22.872 | 23.594 | 12.83 | 16.43 | 14.913 | 16.716 | 11.489 | 7.509 | 5.93 | 6.674 |
Selling & Marketing Expenses
| 609.499 | 586.368 | 604.24 | 532.259 | 432.285 | 514.163 | 483.199 | 301.321 | 206.915 | 237.259 | 230.604 | 181.505 | 115.119 | 101.743 | 85.487 | 79.148 | 65.029 | 64.926 | 48.884 | 49.133 | 39.18 | 16.511 | 13.882 | 12.653 | 9.066 |
SG&A
| 638.297 | 713.69 | 628.687 | 551.572 | 459.291 | 537 | 502.476 | 315.98 | 216.009 | 245.772 | 242.043 | 192.103 | 117.593 | 105.578 | 90.368 | 102.019 | 88.623 | 77.756 | 65.314 | 64.046 | 55.896 | 28 | 21.392 | 18.584 | 15.74 |
Other Expenses
| 142.809 | 22.389 | 99.72 | 99.815 | 79.16 | 79.822 | -0.779 | -0.503 | 0.623 | 1.747 | -0.307 | -0.635 | 0.542 | -0.101 | 0.583 | 0.454 | 5.362 | 9.976 | -0.78 | 0.694 | 0.618 | 0.036 | 0.06 | 0.715 | -1.621 |
Operating Expenses
| 935.695 | 869.226 | 820.846 | 717.861 | 582.47 | 663.789 | 607.162 | 385.841 | 282.239 | 306.058 | 289.613 | 237.583 | 142.023 | 127.908 | 112.575 | 104.572 | 90.983 | 79.625 | 67.297 | 65.339 | 56.486 | 28.415 | 22.449 | 19.539 | 16.33 |
Operating Income
| 131.019 | 174.772 | 187.046 | 156.233 | 143.205 | 101.769 | 88.602 | 90.42 | 76.629 | 58.933 | 53.713 | 46.61 | 33.535 | 29.399 | 23.929 | 19.323 | 12.061 | 8.059 | 13.782 | 12.026 | 12.954 | 18.524 | 24.165 | 20.532 | 15.201 |
Operating Income Ratio
| 0.061 | 0.08 | 0.096 | 0.095 | 0.103 | 0.079 | 0.087 | 0.131 | 0.127 | 0.092 | 0.08 | 0.075 | 0.103 | 0.091 | 0.083 | 0.074 | 0.054 | 0.041 | 0.083 | 0.07 | 0.071 | 0.165 | 0.308 | 0.297 | 0.235 |
Total Other Income Expenses Net
| -0.591 | 0.26 | 2.007 | 3.33 | -1.245 | -0.306 | -0.779 | -0.503 | 0.576 | 1.675 | -0.757 | -0.845 | -0.591 | -1.114 | 0.48 | -0.051 | 5.21 | 9.904 | -0.136 | 0.751 | 0.664 | -0.554 | -0.35 | -0.181 | -2.58 |
Income Before Tax
| 130.428 | 175.032 | 189.053 | 159.563 | 141.961 | 101.463 | 87.822 | 89.917 | 77.182 | 60.608 | 52.957 | 45.766 | 34.041 | 29.261 | 24.409 | 19.438 | 17.271 | 17.963 | 12.504 | 11.415 | 12.42 | 17.97 | 23.815 | 20.351 | 12.62 |
Income Before Tax Ratio
| 0.06 | 0.081 | 0.097 | 0.097 | 0.102 | 0.079 | 0.086 | 0.13 | 0.128 | 0.094 | 0.079 | 0.073 | 0.105 | 0.09 | 0.084 | 0.075 | 0.077 | 0.092 | 0.075 | 0.066 | 0.069 | 0.16 | 0.303 | 0.294 | 0.195 |
Income Tax Expense
| 24.013 | 23.692 | 22.611 | 19.662 | 21.809 | 18.214 | 13.653 | 19.361 | 14.656 | 10.602 | 9.064 | 7.448 | 5.383 | 4.747 | 4.17 | 3.193 | 4.309 | 8.06 | 4.6 | 4.056 | 5.222 | 6.884 | 8.039 | 6.707 | 5.356 |
Net Income
| 84.16 | 135.009 | 141.371 | 118.839 | 103.002 | 79.731 | 73.557 | 70.547 | 62.69 | 50.115 | 43.995 | 38.326 | 28.656 | 24.508 | 20.334 | 17.199 | 13.145 | 10.147 | 8.1 | 7.571 | 7.258 | 11.249 | 15.776 | 13.645 | 7.264 |
Net Income Ratio
| 0.039 | 0.062 | 0.072 | 0.072 | 0.074 | 0.062 | 0.072 | 0.102 | 0.104 | 0.078 | 0.066 | 0.061 | 0.088 | 0.076 | 0.07 | 0.066 | 0.058 | 0.052 | 0.049 | 0.044 | 0.04 | 0.1 | 0.201 | 0.197 | 0.112 |
EPS
| 0.29 | 0.47 | 0.5 | 0.42 | 0.36 | 0.28 | 0.26 | 0.25 | 0.22 | 0.18 | 0.17 | 0.14 | 0.13 | 0.12 | 0.077 | 0.087 | 0.053 | 0.039 | 0.03 | 0.022 | 0.021 | 0.032 | 0.068 | 0.053 | 0.028 |
EPS Diluted
| 0.29 | 0.47 | 0.5 | 0.42 | 0.36 | 0.28 | 0.26 | 0.25 | 0.22 | 0.18 | 0.17 | 0.14 | 0.13 | 0.12 | 0.077 | 0.087 | 0.053 | 0.039 | 0.03 | 0.022 | 0.021 | 0.032 | 0.068 | 0.053 | 0.028 |
EBITDA
| 215.957 | 259.879 | 255.045 | 206.714 | 180.884 | 131.085 | 114.939 | 118.827 | 104.464 | 81.039 | 75.589 | 62.027 | 49.484 | 42.048 | 36.463 | 31.053 | 28.489 | 24.216 | 17.822 | 16.539 | 17.055 | 22.317 | 28.739 | 22.003 | 14.673 |
EBITDA Ratio
| 0.1 | 0.12 | 0.13 | 0.126 | 0.131 | 0.102 | 0.113 | 0.172 | 0.173 | 0.126 | 0.113 | 0.1 | 0.152 | 0.13 | 0.126 | 0.119 | 0.126 | 0.124 | 0.107 | 0.096 | 0.094 | 0.199 | 0.366 | 0.318 | 0.227 |